Please login to the form below

Not currently logged in
Email:
Password:

Mimpara

This page shows the latest Mimpara news and features for those working in and with pharma, biotech and healthcare.

NICE set to back Parsabiv for kidney disease complication

NICE set to back Parsabiv for kidney disease complication

be treated with Amgen's older drug Sensipar/Mimpara (cinacalcet) - and provided Amgen supplies the drug at an agreed discount.

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • PAN and DJM win prestigious Global Award

    Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their animation of Mimpara Man’ for Amgen. ... Creative agency PAN and sister digital agency DJM Solutions have won a prestigious Global Award for their

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics